Phoenix Life Sciences International Limited. Retained Earnings
Phoenix Life Sciences International Limited. had Retained Earnings of -$24.02 million as of 2019-02-28, per its 10-K filed 2020-04-10.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-04-10
- 2019-02-28: Retained Earnings (Accumulated Deficit) -$24.02M.
- 2018-11-30: Retained Earnings (Accumulated Deficit) -$23.44M.
- 2018-08-31: Retained Earnings (Accumulated Deficit) -$19.59M.
- 2018-05-31: Retained Earnings (Accumulated Deficit) -$19.29M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2019-02-28 | -$24.02M 10-K · filed 2020-04-10 | |
| 2018-11-30 | -$23.44M 10-Q · filed 2019-05-24 | |
| 2018-08-31 | -$19.59M 10-Q · filed 2019-04-25 | |
| 2018-05-31 | -$19.29M 10-Q · filed 2019-04-25 | |
| 2018-02-28 | -$19.15M 10-K · filed 2020-04-10 | |
| 2017-11-30 | -$18.89M 10-Q · filed 2019-04-19 | |
| 2017-08-31 | -$18.89M 10-Q · filed 2019-04-19 | |
| 2017-05-31 | -$18.89M 10-Q · filed 2019-04-19 | |
| 2017-02-28 | -$19.07M 10-K · filed 2019-04-22 | |
| 2016-11-30 | -$18.82M 10-Q · filed 2019-04-18 | |
| 2016-08-31 | -$18.77M 10-Q · filed 2019-04-18 | |
| 2016-05-31 | -$18.93M 10-Q · filed 2019-04-17 | |
| 2016-02-29 | -$18.82M 10-Q · filed 2019-04-18 | |
| 2015-11-30 | -$18.59M 10-Q · filed 2019-04-16 | |
| 2015-08-31 | -$13.70M 10-Q · filed 2016-01-19 | |
| 2015-05-31 | -$13.15M 10-Q · filed 2015-08-10 | |
| 2015-02-28 | -$18.03M 10-Q · filed 2019-04-16 | -$12.64M 10-K · filed 2015-07-29 |
| 2014-11-30 | -$2.93M 10-Q · filed 2015-03-09 | |
| 2014-08-31 | -$1.73M 10-Q · filed 2014-11-25 | |
| 2014-02-28 | -$667.25K 10-K/A · filed 2019-03-04 | |
| 2013-11-30 | -$74.61K 10-Q · filed 2014-01-21 | |
| 2013-08-31 | -$74.61K 10-Q · filed 2013-10-21 | |
| 2013-02-28 | -$74.61K 10-Q · filed 2014-01-21 |